XML 28 R14.htm IDEA: XBRL DOCUMENT v3.23.3
Property, plant and equipment, net
 9 Months Ended
Sep. 30, 2023
Property Plant and Equipment Income Statement Disclosures [Abstract]  
Property, plant and equipment, net Property, plant and equipment, net
Property, plant and equipment, net consisted of the following:
September 30, 2023 (1)
December 31, 2022
Land and improvements$30.0 $54.9 
Buildings, building improvements and leasehold improvements228.9 327.9 
Furniture and equipment428.5 567.5 
Software64.0 65.6 
Construction-in-progress44.9 185.5 
Property, plant and equipment, gross$796.3 $1,201.4 
Less: Accumulated depreciation & amortization(400.9)(383.8)
Total property, plant and equipment, net$395.4 $817.6 
(1) During the nine months ended September 30, 2023, the Company recorded a non-cash impairment charge of $306.7 million related to certain CDMO long-lived assets. See Note 4, "Long-lived asset impairment and restructuring charges" for more details regarding the impairment charge.
As of September 30, 2023, construction-in-progress primarily included costs incurred to advance the Company's MCM Product capabilities. As of December 31, 2022, construction-in-progress primarily included costs incurred due to construction to advance the Company's CDMO capabilities.
Property, plant and equipment, net is stated at cost, less accumulated depreciation and amortization. During the year ended December 31, 2022, the Company recorded accelerated depreciation of $12.7 million reflecting a shortening of the useful life of certain property, plant and equipment which were to be used in the manufacturing process to fulfill the manufacturing services agreement (the "Janssen Agreement") with Janssen Pharmaceuticals, Inc. ("Janssen"). For additional information related to the termination of the Janssen Agreement, refer to Note 13, "Revenue recognition".